SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-279968
Filing Date
2015-08-06
Accepted
2015-08-06 07:53:22
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d79922d10q.htm 10-Q 494154
2 EX-31.1 d79922dex311.htm EX-31.1 6680
3 EX-31.2 d79922dex312.htm EX-31.2 6702
4 EX-32.1 d79922dex321.htm EX-32.1 2860
5 EX-32.2 d79922dex322.htm EX-32.2 2956
  Complete submission text file 0001193125-15-279968.txt   3394402

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20150630.xml EX-101.INS 453878
7 XBRL TAXONOMY EXTENSION SCHEMA infi-20150630.xsd EX-101.SCH 55749
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE infi-20150630_cal.xml EX-101.CAL 59190
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE infi-20150630_def.xml EX-101.DEF 258939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20150630_lab.xml EX-101.LAB 402296
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20150630_pre.xml EX-101.PRE 297302
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 151031138
SIC: 2834 Pharmaceutical Preparations